Novel glucoconjugates phenolic moiety, 3-(methoxycarbonyl)-4-(hydroxyphenyl)-$eta$-D-glucopyranoside(4), 3-(methoxyacetyl)-4-(hydroxyphenyl)-$eta$-D-glucopyranoside(7), 4-(hydroxyphenyl)-$eta$-D-ribofuranoside(11), were synthesized. In order to investigate their depigmentation effect, inhibitory activity against mushroom tyrosinase and inhibitory activity of melanin synthesis in B16 melanoma cell were evaluated in vitro. Compound 11 showed 92.0$mu extrm{g}$/㎖ of tyrosinase inhibitory activity whereas compound 4 and 7 showed very low activity not less than 300$mu extrm{g}$/㎖. Inhibitory activities of melanin synthesis in B16 melanoma cell of compound 4, 7, and 11 were 8.7, 15.1, and 36.0%, respectively, at the concentration of 100$mu extrm{g}$/㎖. Inhibitory activity of compound 11 was much higher than that of arbutin at the same concentration.